Old Web
English
Sign In
Acemap
>
authorDetail
>
Anna Ndiaye
Anna Ndiaye
Pasteur Institute
Virology
Shigella dysenteriae
Antibody
Immunology
Shiga toxin
2
Papers
50
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial.
2009
Vaccine
Odile Launay
Christine Sadorge
Nathalie Jolly
Béatrice Poirier
Stéphane Béchet
Diane van der Vliet
Valérie Seffer
Nicola Fenner
Kelly Dowling
Raphaela Giemza
Julie M Johnson
Anna Ndiaye
Muriel Vray
Philippe J. Sansonetti
Philippe Morand
Claire Poyart
David J.M. Lewis
Marie-Lise Gougeon
Show All
Source
Cite
Save
Citations (33)
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA: HgR oral vaccine SC599 in healthy human adult volunteers
2008
Vaccine
Christine Sadorge
Anna Ndiaye
Nathalie Beveridge
Schale Frazer
Rafaela Giemza
Nathalie Jolly
Julie M Johnson
Helen Liddy
Catherine A. Cosgrove
Paola Allavena
Alberto Mantovani
Stéphane Béchet
Annick Fontaine-Thompson
George E. Griffin
Francis Dupont
Philippe J. Sansonetti
David J.M. Lewis
Show All
Source
Cite
Save
Citations (17)
1